Germline Brca2 Heterozygosity Promotes KrasG12D -Driven Carcinogenesis in a Murine Model of Familial Pancreatic Cancer (Q39635066)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on November 4, 2010

Language	Label	Description	Also known as
English	Germline Brca2 Heterozygosity Promotes KrasG12D -Driven Carcinogenesis in a Murine Model of Familial Pancreatic Cancer	scientific article published on November 4, 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Germline Brca2 heterozygosity promotes Kras(G12D) -driven carcinogenesis in a murine model of familial pancreatic cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Germline Brca2 Heterozygosity Promotes KrasG12D -Driven Carcinogenesis in a Murine Model of Familial Pancreatic Cancer (English)

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

1 reference

based on heuristic

inferred from title

pancreatic cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

animal disease model

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21056012

21 August 2024

germline mutation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21056012

21 August 2024

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21056012

21 August 2024

13

object named as

David A Tuveson

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

2

object named as

Liam D. Cassidy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21056012

21 August 2024

Florian Karreth

7

object named as

Florian A. Karreth

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21056012

21 August 2024

8

object named as

Michael Lim

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21056012

21 August 2024

Kenneth P Olive

12

object named as

Kenneth P. Olive

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21056012

21 August 2024

author name string

Ferdinandos Skoulidis

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Venkat Pisupati

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Hordur Bjarnason

5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Jon G. Jonasson

4

0000-0002-2635-5032

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21056012

21 August 2024

Jorunn E. Eyfjord

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21056012

21 August 2024

Lorraine M. Barber

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21056012

21 August 2024

Susan A. Clatworthy

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21056012

21 August 2024

Susan E. Davies

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21056012

21 August 2024

David A. Tuveson

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21056012

21 August 2024

Ashok R. Venkitaraman

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21056012

21 August 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21056012

21 August 2024

publication date

4 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

full work available at URL

http://www.cell.com/article/S1535610810004204/pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21056012

21 August 2024

https://api.elsevier.com/content/article/PII:S1535610810004204?httpAccept=text/xml

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

https://api.elsevier.com/content/article/PII:S1535610810004204?httpAccept=text/plain

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

499-509

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

1

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

The carboxyl terminus of Brca2 links the disassembly of Rad51 complexes to mitotic entry

2

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

Cancer risks in BRCA2 mutation carriers

3

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

4

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

K-ras mutation and pancreatic adenocarcinoma

5

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment

6

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

The prevalence of BRCA2 mutations in familial pancreatic cancer

8

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects

9

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

10

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers

11

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval

12

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

Thymic lymphomas in mice with a truncating mutation in Brca2

13

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

Gene-specific selection against experimental fanconi anemia gene inactivation in human cancer

14

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

High-throughput SNP allele-frequency determination in pooled DNA samples by kinetic PCR.

15

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas

16

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications

17

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13

18

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

BRCA2 germline mutations in familial pancreatic carcinoma

19

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

Genetics and biology of pancreatic ductal adenocarcinoma.

20

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse

21

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice

22

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions

23

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene

25

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer.

26

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesis

27

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

Mutation and cancer: statistical study of retinoblastoma

28

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos

29

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

Pancreatic cancer.

30

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

The Icelandic founder mutation BRCA2 999del5: analysis of expression

31

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome

32

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer

33

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

Loss of heterozygosity analysis at theBRCAloci in tumor samples from patients with familial breast cancer

34

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

Physiological analysis of oncogenic K-ras

35

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions

36

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

Analysis of murine Brca2 reveals conservation of protein-protein interactions but differences in nuclear localization signals

37

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

Successful growth and characterization of mouse pancreatic ductal cells: functional properties of the Ki-RAS(G12V) oncogene

38

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes

39

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

Study of a single BRCA2 mutation with high carrier frequency in a small population

40

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

41

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor

42

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

Linking the cellular functions of BRCA genes to cancer pathogenesis and treatment

43

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

RAD51 Interacts with the Evolutionarily Conserved BRC Motifs in the Human Breast Cancer Susceptibility Gene brca2

44

1 reference

10.1016/J.CCR.2010.10.015

https://api.crossref.org/works/10.1016/J.CCR.2010.10.015

21 August 2024

Identifiers

10.1016/J.CCR.2010.10.015

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

release_rfaghgx3bza3tpdhjjowhs6rey

1 reference

https://api.fatcat.wiki/v0/release/rfaghgx3bza3tpdhjjowhs6rey

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39635066&oldid=2233205946"